Telephone sharing button Contact Us linkedin sharing button Share wechat sharing button Share wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Locations

Total estimated capacity for biopharmaceutical production in China, Ireland, the U.S., Germany and Singapore to exceed 430,000 liters by 2024.

United States
Massachusetts
U.S.
107,000sq. ft.
Operational2023
New Jersey
U.S.
66,000sq. ft.
Operational2021
Pennsylvania
U.S.
33,000sq. ft.
OperationalOctober. 2020
Ireland
Dundalk
Ireland
26Hectare campus
Operations2021
WuXi Vaccines
Ireland
$240Million investment
Operational2022
Germany
Leverkusen
Germany
13,000+sq.m. facility
Operations2020
Wuppertal
Germany
30,000sq. m.
Operational2021
Singapore
Singapore
$60Million investment
Operational2022
China
Shanghai
Waigaoqiao Free Trade Zone
17,748sq. m.
openedOctober 2011
Shanghai
Fengxian District
1.6 millionsq. ft.
Planned2021
Wuxi
160,000sq.m.
OpenedOctober 2012
Suzhou
Wuzhong District
10,100sq. m.
OpenedDecember 2014
Hangzhou
30,000sq. m.
Operational2020
Chengdu
314,000sq. m.
Planned2023
Shijiazhuang
82,160sq. m.
Planned2022
Hangzhou
50,000sq. m.
opened2018
Suzhou
Industrial Park
11,500sq. m.
opened2017
Notice:

You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?